These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 8613959

  • 1. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
    Bilsky EJ, Bernstein RN, Hruby VJ, Rothman RB, Lai J, Porreca F.
    J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
    [Abstract] [Full Text] [Related]

  • 2. Treatment with antisense oligodeoxynucleotide to a conserved sequence of opioid receptors inhibits antinociceptive effects of delta subtype selective ligands.
    Lai J, Bilsky EJ, Porreca F.
    J Recept Signal Transduct Res; 1995 Apr; 15(1-4):643-50. PubMed ID: 8903970
    [Abstract] [Full Text] [Related]

  • 3. Selective inhibition of [D-Ala2, Glu4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor.
    Bilsky EJ, Bernstein RN, Pasternak GW, Hruby VJ, Patel D, Porreca F, Lai J.
    Life Sci; 1994 Apr; 55(2):PL37-43. PubMed ID: 8015351
    [Abstract] [Full Text] [Related]

  • 4. In vivo injection of antisense oligodeoxynucleotides to G alpha subunits and supraspinal analgesia evoked by mu and delta opioid agonists.
    Sánchez-Blázquez P, García-España A, Garzón J.
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1590-6. PubMed ID: 8531133
    [Abstract] [Full Text] [Related]

  • 5. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat.
    Fraser GL, Pradhan AA, Clarke PB, Wahlestedt C.
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1135-41. PubMed ID: 11082450
    [Abstract] [Full Text] [Related]

  • 6. delta Opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception.
    Sánchez-Blázquez P, Garzón J.
    J Pharmacol Exp Ther; 1998 May; 285(2):820-7. PubMed ID: 9580632
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
    Jiang Q, Takemori AE, Sultana M, Portoghese PS, Bowen WD, Mosberg HI, Porreca F.
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
    [Abstract] [Full Text] [Related]

  • 9. Interaction between medullary and spinal delta1 and delta2 opioid receptors in the production of antinociception in the rat.
    Hurley RW, Grabow TS, Tallarida RJ, Hammond DL.
    J Pharmacol Exp Ther; 1999 May; 289(2):993-9. PubMed ID: 10215679
    [Abstract] [Full Text] [Related]

  • 10. Treatment with antisense oligodeoxynucleotide to the opioid delta receptor selectively inhibits delta 2-agonist antinociception.
    Lai J, Bilsky EJ, Rothman RB, Porreca F.
    Neuroreport; 1994 May 09; 5(9):1049-52. PubMed ID: 8080957
    [Abstract] [Full Text] [Related]

  • 11. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.
    Mattia A, Vanderah T, Mosberg HI, Porreca F.
    J Pharmacol Exp Ther; 1991 Aug 09; 258(2):583-7. PubMed ID: 1650835
    [Abstract] [Full Text] [Related]

  • 12. Selective blockade of peripheral delta opioid agonist induced antinociception by intrathecal administration of delta receptor antisense oligodeoxynucleotide.
    Bilsky EJ, Wang T, Lai J, Porreca F.
    Neurosci Lett; 1996 Dec 20; 220(3):155-8. PubMed ID: 8994216
    [Abstract] [Full Text] [Related]

  • 13. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
    Qi JA, Bowen WD, Mosberg HI, Rothman RB, Porreca F.
    J Pharmacol Exp Ther; 1990 Nov 20; 255(2):636-41. PubMed ID: 2173752
    [Abstract] [Full Text] [Related]

  • 14. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
    Mattia A, Farmer SC, Takemori AE, Sultana M, Portoghese PS, Mosberg HI, Bowen WD, Porreca F.
    J Pharmacol Exp Ther; 1992 Feb 20; 260(2):518-25. PubMed ID: 1310737
    [Abstract] [Full Text] [Related]

  • 15. Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors.
    Sánchez-Blázquez P, García-Espãna A, Garzón J.
    J Pharmacol Exp Ther; 1997 Mar 20; 280(3):1423-31. PubMed ID: 9067332
    [Abstract] [Full Text] [Related]

  • 16. Differential knockdown of delta-opioid receptor subtypes in the rat brain by antisense oligodeoxynucleotides targeting mRNA.
    Negri L, Lattanzi R, Borsodi A, Toth G, Salvadori S.
    Antisense Nucleic Acid Drug Dev; 1999 Apr 20; 9(2):203-11. PubMed ID: 10355826
    [Abstract] [Full Text] [Related]

  • 17. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
    Cao YJ, Bian JT, Bhargava HN.
    Eur J Pharmacol; 1997 Sep 24; 335(2-3):161-6. PubMed ID: 9369369
    [Abstract] [Full Text] [Related]

  • 18. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L, Lee NM.
    J Pharmacol Exp Ther; 1998 Jun 24; 285(3):1181-6. PubMed ID: 9618421
    [Abstract] [Full Text] [Related]

  • 19. Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.
    Horan PJ, Wild KD, Misicka A, Lipkowski A, Haaseth RC, Hruby VJ, Weber SJ, Davis TP, Yamamura HI, Porreca F.
    J Pharmacol Exp Ther; 1993 May 24; 265(2):896-902. PubMed ID: 8388462
    [Abstract] [Full Text] [Related]

  • 20. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
    Cahill CM, White TD, Sawynok J.
    J Pharmacol Exp Ther; 1995 Oct 24; 275(1):84-93. PubMed ID: 7562600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.